Skip to main content

Table 3 Cumulative incidence of clinical events during the follow-up period

From: Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention

  DM (n=452) PH (n=236) NGT (n=140) P value
MACE 178 (39.3)*† 74 (31.4)† 29 (20.7) <0.001
All-cause Death 37 (8.1)*† 8 (3.3) 3 (2.1) 0.006
Non-cardiovascular 21 (4.6) 4 (1.6) 3 (2.1) 0.08
Cardiovascular 16 (3.5) 4 (1.6) 0 (0.0) 0.041
Stroke 20 (4.4) 8 (3.3) 3 (2.1) 0.5
MI 12 (2.6) 6 (2.5) 2 (1.4) 0.7
Revascularization 159 (35.1)*† 64 (27.1) 26 (18.5) <0.001
PCI 157 (34.7)*† 63 (26.6) 26 (18.5) <0.001
TLR 47 (10.3)† 13 (5.5) 4 (2.8) 0.005
TVR 80 (17.6)*† 27 (11.4) 10 (7.1) 0.002
Non-TVR 101 (22.3) 42 (17.8) 19 (13.5) 0.055
CABG 12 (2.6) 3 (1.2) 0 (0.0) 0.09
  1. Values are expressed as number and percentage. *P <0.05 vs. PH; †P <0.05 vs. NGT. TLR, target lesion revascularization; TVR, target vessel revascularization. Other abbreviations as in Table 1.